Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood advances"
DOI: 10.1182/bloodadvances.2019000756
Abstract: c-KIT activating mutations cause resistance to PARP inhibitor in AML1-ETO–positive leukemias. c-KIT inhibitor avapritinib downregulates BRCA1/2 and DNA-PK catalytic subunit to restore the sensitivity to PARP inhibitor.
read more here.
Keywords:
aml1 eto;
inhibitor;
eto positive;
sensitivity parp ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncology Letters"
DOI: 10.3892/ol.2017.7396
Abstract: Amyloid precursor protein (APP) has been reported to be highly expressed in acute myeloid leukemia (AML)1-eight-twenty one (ETO)-positive AML. In the present study, the clinical and prognostic significance of APP expression was assessed in 65…
read more here.
Keywords:
aml1 eto;
eto positive;
precursor protein;
amyloid precursor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Oncology Reports"
DOI: 10.3892/or.2019.7375
Abstract: Gene mutations play an important role in the development and progression of AML1-ETO-positive acute myeloid leukemia (AE-AML). Nevertheless, the gene mutation profile in this subtype of leukemia remains unclear. In addition, the clinical and prognostic…
read more here.
Keywords:
aml1 eto;
eto positive;
positive acute;
gene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Clinical laboratory"
DOI: 10.7754/clin.lab.2022.220914
Abstract: BACKGROUND The goal was to study the role of the morphology, immunophenotype, karyotype and fusion gene expression in a patient with diagnosis of AML1-ETO positive acute myeloid leukemia. METHODS A case of AML1-ETO positive acute…
read more here.
Keywords:
myeloid leukemia;
leukemia;
expression;
aml1 eto ... See more keywords